Minocycline and Its Impact on Microbial Dysbiosis in the Skin and Gastrointestinal Tract of Acne Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Associations between acne and gastrointestinal comorbidities suggest that microbial dysbiosis and intestinal permeability may promote inflammatory acne, a condition often managed with oral antibiotics. Objective: We performed a case-control study to investigate the skin and gut microbiota in 8 acne patients before and after receiving oral minocycline compared to controls matched by age ±5 years, sex, and race. Methods: DNA was extracted from stool samples and facial skin swabs. Sequencing of the V3V4 region of the bacterial 16S rRNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Acne patients included 7 female and 1 male, ages 20∼ 32. Shannon diversity was not significantly different between the skin (p=0.153) or gut (p<0.999) microbiota of acne patients before and after antibiotics. The gut microbiota in pre-antibiotic acne patients compared to acne-free controls was depleted in probiotics Lactobacillus iners (p=0.001), Lactobacillus zeae (p=0.001), and Bifidobacterium animalis (p=0.026). After antibiotics, the gut microbiota of acne patients was depleted in Lactobacillus salivarius (p=0.001), Bifidobacterium adolescentis (p=0.002), Bifidobacterium pseudolongum (p=0.010), and Bifidobacterium breve (p=0.042), while the skin microbiota was enriched in probiotics Bifidobacterium longum (p=0.028) and Leuconostoc mesenteroides (p=0.029) and depleted in Staphylococcus epidermidis (p=0.009) and Prevotella nigrescens (p=0.028). At the phylum level, significant enrichment of Bacteroidetes in stool of acne patients following antibiotic treatment (p=0.033) led to a decreased Firmicutes to Bacteroidetes ratio. Conclusion: Minocycline produces significant derangements in the microbiota of the skin and gut, including many probiotic species, highlighting the potential for more targeted antimicrobial treatments for acne.
Abstract
Associations between acne and gastrointestinal comorbidities suggest that microbial dysbiosis and intestinal permeability may promote inflammatory acne, a condition often managed with oral antibiotics. Objective: We performed a case-control study to investigate the skin and gut microbiota in 8 acne patients before and after receiving oral minocycline compared to controls matched by age ±5 years, sex, and race. Methods: DNA was extracted from stool samples and facial skin swabs. Sequencing of the V3V4 region of the bacterial 16S rRNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Acne patients included 7 female and 1 male, ages 20∼ 32. Shannon diversity was not significantly different between the skin (p=0.153) or gut (p<0.999) microbiota of acne patients before and after antibiotics. The gut microbiota in pre-antibiotic acne patients compared to acne-free controls was depleted in probiotics Lactobacillus iners (p=0.001), Lactobacillus zeae (p=0.001), and Bifidobacterium animalis (p=0.026). After antibiotics, the gut microbiota of acne patients was depleted in Lactobacillus salivarius (p=0.001), Bifidobacterium adolescentis (p=0.002), Bifidobacterium pseudolongum (p=0.010), and Bifidobacterium breve (p=0.042), while the skin microbiota was enriched in probiotics Bifidobacterium longum (p=0.028) and Leuconostoc mesenteroides (p=0.029) and depleted in Staphylococcus epidermidis (p=0.009) and Prevotella nigrescens (p=0.028). At the phylum level, significant enrichment of Bacteroidetes in stool of acne patients following antibiotic treatment (p=0.033) led to a decreased Firmicutes to Bacteroidetes ratio. Conclusion: Minocycline produces significant derangements in the microbiota of the skin and gut, including many probiotic species, highlighting the potential for more targeted antimicrobial treatments for acne.
참고문헌 (60)
- Hicks LA, "US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011", Clin Infect Dis, 60, pp.1308~1316 (2015)
- Del Rosso JQ, "Status report from the scientific panel on antibiotic use in dermatology of the American Acne and Rosacea Society: part 1: antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use", J Clin Aesthet Dermatol, 9, pp.18~24 (2016)
- Coates P, "Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients : 10-year surveillance data and snapshot distribution study", Br J Dermatol, 146, pp.840~848 (2002)
- Ross JI, "Antibiotic-resistant acne : lessons from Europe", Br J Dermatol, 148, pp.467~478 (2003)
- Simonart T, "Treatment of acne with topical antibiotics : lessons from clinical studies", Br J Dermatol, 153, pp.395~403 (2005)
- Levy RM, "Effect of antibiotics on the oropharyngeal flora in patients with acne", Arch Dermatol, 139, pp.467~471 (2003)
- Mills O Jr, "Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle", Acta Derm Venereol, 82, pp.260~265 (2002)
- Zhang H, "Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents", J Dermatol, 35, pp.555~561 (2008)
- Stokes JH, "The effect on the skin of emotional and nervous states Iii. Theoretical and practical consideration of a gastro-intestinal mechanism", Arch Derm Syphilol, 22, pp.962~993 (1930)
- Lauritano EC, "Small intestinal bacterial overgrowth and intestinal permeability", Scand J Gastroenterol, 45, pp.1131~1132 (2010)
- Juhlin L, "Fibrin microclot formation in patients with acne", Acta Derm Venereol, 63, pp.538~540 (1983)
- Terhorst D, "The role of toll-like receptors in host defenses and their relevance to dermatologic diseases", Am J Clin Dermatol, 11, pp.1~10 (2010)
- Deng Y, "Patients with acne vulgaris have a distinct gut microbiota in comparison with healthy controls", Acta Derm Venereol, 98, pp.783~790 (2018)
- Ou J, "Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans", Am J Clin Nutr, 98, pp.111~120 (2013)
- Yatsunenko T, "Human gut microbiome viewed across age and geography", Nature, 486, pp.222~227 (2012)
- Obregon-Tito AJ, "Subsistence strategies in traditional societies distinguish gut microbiomes", Nat Commun, 6, pp.6505~ (2015)
- Gomez A, "Gut microbiome of coexisting BaAka pygmies and bantu reflects gradients of traditional subsistence patterns", Cell Rep, 14, pp.2142~2153 (2016)
- De Filippo C, "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proc Natl Acad Sci U S A, 107, pp.14691~14696 (2010)
- O’Brien SC, "The Leeds revised acne grading system", J Dermatolog Treat, 9, pp.215~220 (1998)
- Roghmann MC, "Comparison of the microbiota of older adults living in nursing homes and the community", mSphere, 2, pp.e00210~e00217 (2017)
- Bromberg JS, "Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes", JCI Insight, 3, pp.121045~ (2018)
- Fadrosh DW, "An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform", Microbiome, 2, pp.6~ (2014)
- Caporaso JG, "QIIME allows analysis of high-throughput community sequencing data", Nat Methods, 7, pp.335~336 (2010)
- White JR, "Statistical methods for detecting differentially abundant features in clinical metagenomic samples", PLoS Comput Biol, 5, pp.e1000352~ (2009)
- Clarke KR, "Non-parametric multivariate analyses of changes in community structure", Austral Ecol, 18, pp.117~143 (1993)
- Loveman DE, "Comparative studies of enteric bacterial flora in acne vulgaris", J Invest Dermatol, 25, pp.135~137 (1955)
- Chien AL, "Association of systemic antibiotic treatment of acne with skin microbiota characteristics", JAMA Dermatol, 155, pp.425~434 (2019)
- Fukuda S, "Bifidobacteria can protect from enteropathogenic infection through production of acetate", Nature, 469, pp.543~547 (2011)
- Romijn AR, "A doubleblind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression", Aust N Z J Psychiatry, 51, pp.810~821 (2017)
- Allen AP, "Bifidobacterium longum 1714 as a translational psychobiotic : modulation of stress, electrophysiology and neurocognition in healthy volunteers", Transl Psychiatry, 6, pp.e939~ (2016)
- Pujato SA, "Leuconostoc mesenteroides and Leuconostoc pseudomesenteroides bacteriophages : Genomics and crossspecies host ranges", Int J Food Microbiol, 257, pp.128~137 (2017)
- Matsuzaki C, "Structural characterization of the immunostimulatory exopolysaccharide produced by Leuconostoc mesenteroides strain NTM048", Carbohydr Res, 448, pp.95~102 (2017)
- Zununi Vahed S, "Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB", AKT, MAPK pathways, pp.Biomed Pharmacother, 2017[DOI]
- Wang YY, "Chlorin e6-mediated photodynamic therapy suppresses P. acnes-induced inflammatory response via NFκB and MAPKs signaling pathway", PLoS One, 12, pp.e0170599~ (2017)
- Chen Q, "Propionibacterium acnes-induced IL-8 production may be mediated by NF-kappaB activation in human monocytes", J Dermatol Sci, 29, pp.97~103 (2002)
- Wang Y, "Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes : implications of probiotics in acne vulgaris", Appl Microbiol Biotechnol, 98, pp.411~424 (2014)
- Xia X, "Staphylococcal LTA-induced miR-143 inhibits propionibacterium acnes-mediated inflammatory response in skin", J Invest Dermatol, 136, pp.621~630 (2016)
- Lie MA, "Occurrence of Prevotella intermedia and Prevotella nigrescens in relation to gingivitis and gingival health", J Clin Periodontol, 28, pp.189~193 (2001)
- Smith RN, "The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial", J Am Acad Dermatol, 57, pp.247~256 (2007)
- Falsen E, "Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov", Int J Syst Bacteriol, 49(Pt 1), pp.217~221 (1999)
- Zhou M, "Lactobacillus zeae protects Caenorhabditis elegans from enterotoxigenic Escherichia coli-caused death by inhibiting enterotoxin gene expression of the pathogen", PLoS One, 9, pp.e89004~ (2014)
- Jungersen M, "The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12(Ⓡ)", Microorganisms, 2, pp.92~110 (2014)
- Messaoudi S, "Lactobacillus salivarius : bacteriocin and probiotic activity", Food Microbiol, 36, pp.296~304 (2013)
- O'Shea EF, "Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius", J Bacteriol, 193, pp.6973~6982 (2011)
- Lee J, "Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by bifidobacterium adolescentis M101-4", Biosci Biotechnol Biochem, 57, pp.2127~2132 (1993)
- Li D, "Anti-viral Effect of Bifidobacterium adolescentis against noroviruses", Front Microbiol, 7, pp.864~ (2016)
- Hyang Mi An, "Antiviral Activity of Bifidobacterium adolescentis SPM 0214 against Herpes Simplex Virus Type 1", Archives of Pharmacal Research, 35(9), pp.1665~1671 (2012), 대한약학회
- Cha MK, "Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16", BMC Med, 10, pp.72~ (2012)
- Kim MJ, "Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3", Biotechnol Biotechnol Equip, 28, pp.681~688 (2014)
- Mangin I, "Oral administration of viable Bifidobacterium pseudolongum strain Patronus modified colonic microbiota and increased mucus layer thickness in rat", FEMS Microbiol Ecol, 94 (2018)
- Pélissier MA, "Metronidazole effects on microbiota and mucus layer thickness in the rat gut", FEMS Microbiol Ecol, 73, pp.601~610 (2010)
- van der Waaij LA, "Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes : commensal bacteria live in suspension and have no direct contact with epithelial cells", Inflamm Bowel Dis, 11, pp.865~871 (2005)
- Mantis NJ, "Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut", Mucosal Immunol, 4, pp.603~611 (2011)
- van der Meulen TA, "The microbiome-systemic diseases connection", Oral Dis, 22, pp.719~734 (2016)
- Mogna L, "Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains", J Clin Gastroenterol, 46(Suppl), pp.S29~S29 (2012)
- Aloisio I, "Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns", Appl Microbiol Biotechnol, 96, pp.1561~1576 (2012)
- Lorenzo Drago, "Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics", Allergy, Asthma & Immunology Research, 7(4), pp.409~413 (2015), 대한천식알레르기학회
- Klemenak M, "Administration of Bifidobacterium breve decreases the production of TNF-α in children with celiac disease", Dig Dis Sci, 60, pp.3386~3392 (2015)
- Ozkanli S, "A comparative study of MMP-1, MMP-2, and TNF-α expression in different acne vulgaris lesions", Int J Dermatol, 55, pp.1402~1407 (2016)
- Jung GW, "Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne", J Cutan Med Surg, 17, pp.114~122 (2013)
